An2 Therapeutics, Inc. · NASDAQ:ANTX

BML Investment Partners, L.P. reported a 19.10% stake in An2 Therapeutics, Inc. (Schedule 13D)

Event May 7, 2025 · Filed May 7, 2025

BML Investment Partners, L.P. reported a 19.10% stake in An2 Therapeutics, Inc., 5,749,432 shares, with active intent on May 7, 2025. Filed May 7, 2025 (Schedule 13D).

Stake
19.10%
Shares
5,749,432
Intent
Active
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BML Investment Partners, L.P.19.10%5,749,432

Source

View original at SEC

Related